NHF is pleased to announce that two new resources have been added to the Nurses’ Guide to Bleeding Disorders (NGBD), both of which were developed to be practical guidelines for the preparation and administration of bleeding disorders therapies.…
NHF requests members of the inheritable blood disorders community be informed of a recent FDA recall involving Monoject™ Flush Prefilled Saline Syringes. Please see the below and discuss with your physician for more information. Patients who would…
Media ContactIlana Ostrin, Senior Director of Public Relations & CommunicationsTime sensitive requests: 212-328-3769 (call or text)Non-urgent requests: iostrin@hemophilia.org About NBDFFor nearly 75 years, The National Bleeding Disorders…
FOR IMMEDIATE RELEASE
MEDIA CONTACT:
Ilana Ostrin
212-328-3769
iostrin@hemophilia.org
August 23, 2021 — New York City —The annual Bleeding Disorders Conference (BDC),…
Gene Therapy for Inheritable Bleeding Disorders
Speaker: Valder R. Arruda. MD, PhD - Children's Hospital of Philadelphia
NHF's Wednesday Webinars are a free education series open to providers and community…
A new review article, “The Intersection of Vector Biology, Gene Therapy, and Hemophilia,” was published recently in the journal Research Practice in Thrombosis & Haemostasis (RPTH). It provides a comprehensive overview of the scientific…
September 7, 2021
FOR IMMEDIATE RELEASE
Media Contacts
Ilana Ostrin, National Hemophilia Foundation
iostrin@hemophilia.org
212-328-3769
Meghan Lawton, Hemophilia Federation of America…
CSL Behring announced that the company’s distribution agreement with Ferring Pharmaceuticals for STIMATE® nasal spray recently expired and will not be renewed effectively removing this medication as a valuable treatment option for patients with von…